|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,054.00 GBX | +0.39% |
|
-3.25% | +12.52% |
| 03:40pm | US FDA Approves Expanded Use of GSK's Wellcovorin for Rare Neurological Condition | MT |
| 03:36pm | Global markets live: Amazon, Meta, Goldman Sachs, OpenAI |
Chart calendar GSK plc
Upcoming events on GSK plc
| 29/04/2026 | Estimated Earnings Release Date (S&P Global Derived) - Q1 2026 | ~ 08:00 |
Past events on GSK plc
| 04/02/2026 | Earnings release - Q4 2025 | 07:00 |
| 04/02/2026 | Earnings presentation | 11:00 |
| 29/10/2025 | Earnings presentation | 12:00 |
| 29/10/2025 | Earnings release - Q3 2025 | ~ 06:00 |
| 30/07/2025 | Earnings presentation | 12:00 |
| 07/05/2025 | Présentation aux Actionnaires / Analystes | 14:30 |
| 07/05/2025 | Annual General Meeting | Day |
| 30/04/2025 | Earnings presentation | 12:00 |
| 30/04/2025 | Earnings release - Q1 2025 | ~ 07:00 |
Past dividends on GSK plc
| 19/02/2026 | Ex-dividend date - 0.18 GBX | 05:00 |
| 13/11/2025 | Ex-dividend date - 0.16 GBX | 05:00 |
| 14/08/2025 | Ex-dividend date - 0.16 GBX | 05:00 |
| 15/05/2025 | Ex-dividend date - 0.16 GBX | 05:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 30 328 29 850 1.6% | 31 376 31 163 0.68% | 32 667 32 506 0.49% | 33 804 | 35 419 | 36 517 |
|
EBITDA Million GBP | Released Forecast Spread | 11 635 10 203 14.04% | 10 693 10 130 5.56% | 11 278 11 236 0.38% | 11 681 | 12 415 | 12 648 |
|
EBIT Million GBP | Released Forecast Spread | 8 786 8 780 0.07% | 9 148 9 011 1.52% | 9 783 9 649 1.39% | 10 174 | 11 021 | 11 627 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 6 064 7 498 -19.12% | 3 477 4 752 -26.83% | 7 401 6 933 6.76% | 8 098 | 8 990 | 10 028 |
|
Net income Million GBP | Released Forecast Spread | 4 928 5 481 -10.09% | 2 575 3 509 -26.63% | 5 716 5 699 0.3% | 6 311 | 6 796 | 7 183 |
|
EPS GBP | Released Forecast Spread | 1,22 1,38 -11.61% | 0,63 0,85 -25.46% | 1,41 1,39 1.59% | 1,59 | 1,72 | 1,79 |
| Announcement Date | 31/01/24 | 05/02/25 | 04/02/26 | - |
Quarterly results
| Fiscal Period | December | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 7 884 7 493 5.21% | 8 012 8 007 0.06% | 8 117 7 751 4.73% | 7 516 7 455 0.82% | 7 986 7 806 2.31% | 15 502 15 236 1.75% | 8 547 8 251 3.59% | 8 618 8 452 1.96% | 7 657 | 8 301 | 8 922 | 8 917 | 8 070 | 8 650 | 9 270 | 9 275 |
|
EBITDA Million GBP | Released Forecast Spread | 3 152 2 502 25.98% | 3 712 2 788 33.12% | 837 1 650 -49.29% | 3 356 2 603 28.94% | 3 790 2 700 40.37% | 3 723 2 958 25.86% | 409 1 769 -76.87% | 2 826 | 3 003 | 3 287 | 2 369 | |||||
|
EBIT Million GBP | Released Forecast Spread | 2 513 2 205 13.97% | 2 761 2 463 12.1% | 1 431 1 330 7.6% | 2 533 2 302 10.03% | 2 631 2 458 7.03% | 5 164 5 033 2.59% | 2 985 2 647 12.76% | 1 634 1 490 9.69% | 2 453 | 2 598 | 2 977 | 1 998 | 2 865 | 3 047 | 3 441 | 1 985 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 1 495 1 818 -17.77% | 64,0 2 023 -96.84% | 563 919 -38.74% | 2 108 | 2 456 2 396 2.5% | 950 | ||||||||||
|
Net income Million GBP | Released Forecast Spread | 1 173 1 386 -15.4% | -58,0 623 -109.31% | 414 750 -44.82% | 1 624 1 349 20.39% | 1 443 1 396 3.38% | 2 013 1 672 20.38% | 636 835 -23.84% | 1 492 | 1 616 | 1 850 | 1 070 | |||||
|
EPS GBP | Released Forecast Spread | 0,29 0,34 -15.05% | -0,01 0,15 -109.28% | 0,10 0,18 -44.32% | 0,39 0,32 20.94% | 0,35 0,34 3.54% | 0,50 0,41 22% | 0,16 0,20 -22.5% | 0,41 | 0,43 | 0,50 | 0,23 | |||||
| Announcement Date | 31/07/24 | 30/10/24 | 05/02/25 | 30/04/25 | 30/07/25 | 30/07/25 | 29/10/25 | 04/02/26 | - | - | - | - | - | - | - | - |
| 11/03/2026 | Information meeting | Day | |
| 11/03/2026 | Board of Directors Meeting | Day | |
| 11/03/2026 | Earnings release - Annual 2025 | ~ 01:00 | |
| 12/03/2026 | Information meeting | Day | |
| 12/03/2026 | Earnings release - Annual 2025 | ~ 21:00 | |
| 12/03/2026 | Earnings release - Annual 2025 | Day | |
| 12/03/2026 | Earnings presentation | 13:00 | |
| 12/03/2026 | Earnings release - Q4 2025 | ~ 08:00 | |
| 12/03/2026 | Earnings presentation | 17:30 | |
| 12/03/2026 | Earnings release - Annual 2025 | 06:00 |
Past sector events for GSK plc
| Today | Annual General Meeting | 09:30 | |
| Today | Ex-dividend date - 3.7 CHF | 04:00 | |
| Today | Information meeting | Day | |
| Today | Earnings release - Annual 2025 | 16:30 | |
| Today | Earnings presentation | 12:00 | |
| Today | Earnings release - Q4 2025 | ~ 13:30 | |
| Today | Extraordinary General Meeting | 06:00 | |
| Today | Ex-dividend date - 0.168 CNY | 04:00 | |
| 09/03/2026 | Information meeting | 16:00 | |
| 09/03/2026 | Ex-dividend date - 0.12 USD | 04:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GSK Stock
- Calendar GSK plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















